Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Immunoassay for Glandular Fever Is Preferable to Leukocyte Ratio

By LabMedica International staff writers
Posted on 19 Jan 2011
An immunoassay for the detection of infectious mononucleosis heterophile antibodies in whole blood was compared with the ratio of lymphocytes to white cells as diagnostic tests. More...


The immunoassay was a qualitative membrane strip wherein bovine erythrocyte extracted antigen is coated on the test line region of the strip. The lymphocyte counts and white blood cell ratio was calculated and compared with the monospot result to calculate the sensitivity and specificity at various ratios.

Investigators at the Mater Misericordiae University Hospital, (Dublin, Ireland), analyzed 500 positive and 500 negative monospot tests for glandular fever using "Clearview IM" detection kits (Alere Limited, Stockport, UK). These results were compared with the white cell count differentials and specifically the ratio of lymphocytes to total white cell count. The lymphocyte counts and white blood cell ratio was significantly different in the positive and negative monospot groups. The mean lymphocyte counts to white blood cell ratio in the positive group was 0.49, and the mean lymphocyte to white cell count ratio in the monospot negative group was 0.29.

The authors concluded that there is a significant difference between the lymphocyte count in patients with infectious mononucleosis and those with negative monospot tests. An increased lymphocyte count is associated with a positive monospot results and using a lymphocyte to white cell count ratio of 0.35 or greater had a specificity of 72% a sensitivity of 84% for the detection of glandular fever. A higher ratio will give a greater specificity, but a lower sensitivity, and vice versa. The study was published online in November 2010, in the journal Clinical Otolaryngology.

Glandular fever or infectious mononucleosis is caused by an infection with the Epstein-Barr virus and is characterized by fever, sore throat, and fatigue, along with several other possible signs and symptoms. The peak incidence for the onset of glandular fever is between the ages of 15 and 17 and it is estimated that 90% of adults have been exposed to the virus.

Related Links:
Mater Misericordiae University Hospital
Alere Limited



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.